Stay updated on Miransertib in Overgrowth Spectrum Clinical Trial

Sign up to get notified when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Miransertib in Overgrowth Spectrum Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision label on the page was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T19:46:01.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2, indicating an administrative update to the page's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:20:52.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.1 and no longer shows Revision: v3.4.0, a minor metadata update that does not affect study details or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T22:38:12.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now includes a Show glossary option. The labels for QC criteria submission and No FEAR Act data have been updated, and the revision identifier was raised to v3.4.0 from v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T21:27:48.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The update is limited to a minor revision tag (v3.3.4 added; v3.3.3 removed) and does not modify study content, eligibility, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:55:31.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added study site locations: Georgia, Illinois, Massachusetts, Ohio, Texas, Washington, New South Wales, Roma, and Barcelona (revision v3.3.3). Removed corresponding location entries for Georgia, Illinois, Massachusetts, Ohio, Texas, Washington, New South Wales, Roma, and Barcelona (revision v3.3.2).
    Difference
    0.9%
    Check dated 2025-12-23T23:01:42.000Z thumbnail image

Stay in the know with updates to Miransertib in Overgrowth Spectrum Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.